Brief: Biotec Pharmacon Q4 EBITDA loss widens to NOK 8.1 mln
02/02/2017 06:05
Feb 2 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* Q4 revenue 18.2 million Norwegian crowns ($2.2
million)versus 13.1 million crowns year ago
* Q4 EBITDA loss 8.1 million crowns versus loss nok 7.1
million year ago
* Operational targets for 2017 are to finalize UK
reimbursement, drive commercial sales for Woulgan, expand
business opportunities within consumer and animal health segment
Source text for Eikon: ID:nObiQxXpMa
Further company coverage: BIOTEC.OL
($1 = 8.2034 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))